Sequential Autologous Stem Cell Transplantation and Ciltacabtagene Autoleucel for Concurrent Multiple Myeloma and Presumptive Immunoglobulin Heavy- and Light-Chain Amyloidosis in a Patient With Systemic Lupus Erythematosus
Riddhi Patel, Yash Patel, Harshitha Tallapally, Chetan Shah · 2026
Read Sequential Autologous Stem Cell Transplantation and Ciltacabtagene Autoleucel for Concurrent Multiple Myeloma and Presumptive Immunoglobulin Heavy- and Light-Chain Amyloidosis in a Patient With Systemic Lupus Erythematosus by Riddhi Patel, Yash Patel, Harshitha Tallapally, Chetan Shah (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13597170.txt.
Description
Riddhi Patel and colleagues report sequential stem cell transplant and engineered cell therapy in a man carrying three overlapping blood and immune diseases at once. Their 2026 case report covers myeloma, amyloidosis, and lupus in a sixty-seven-year-old patient.
Kidney biopsy first revealed amyloid deposits of two types; marrow biopsy then confirmed concurrent myeloma. He received combination induction drugs, then his own stem cell transplant, then the engineered cell therapy months later. A later marrow biopsy confirmed complete remission of the myeloma. Nearly two years on, he remained off cancer drugs with near-resolved urine protein and stabilised kidney function. Safety data for such therapy with autoimmune disease remain sparse, making the case instructive.
Catalog record
| CREATOR | Riddhi Patel, Yash Patel, Harshitha Tallapally, Chetan Shah |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 20 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |